SPONSOR
Canadian Cancer Trials Group
Total Trials
6
Recruiting
6
Phases
Phase 2, Phase 3
Conditions studied: Hepatocellular CarcinomaCancerAcute LeukemiaGastroesophageal AdenocarcinomaNon-hodgkin LymphomaOropharyngeal Cancer
Canadian Cancer Trials Group is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Hepatocellular Carcinoma, Cancer, Acute Leukemia, Gastroesophageal Adenocarcinoma.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Canadian Cancer Trials Group
How many clinical trials has Canadian Cancer Trials Group sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Canadian Cancer Trials Group, of which 6 are actively recruiting participants. These trials cover conditions including Hepatocellular Carcinoma, Cancer, Acute Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Canadian Cancer Trials Group research focus on?
Canadian Cancer Trials Group clinical trials span Hepatocellular Carcinoma, Cancer, Acute Leukemia, Gastroesophageal Adenocarcinoma, Non-hodgkin Lymphoma, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Canadian Cancer Trials Group clinical trial?
To participate in a Canadian Cancer Trials Group trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Canadian Cancer Trials Group trials with current recruitment status updated daily.
Clinical Trials by Canadian Cancer Trials Group
NCT06880523 Phase 2
Recruiting
STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT03847649 Phase 2
Recruiting
A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies
Cancer
NCT04224974
Recruiting
Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia
Acute Leukemia
NCT06043427 Phase 2
Recruiting
Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
Gastroesophageal Adenocarcinoma
NCT05998642 Phase 2
Recruiting
Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Non-hodgkin Lymphoma
NCT05451004 Phase 3
Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Oropharyngeal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology